Clinical Study Results
Research Sponsor: MedImmune
Treatment Studied: MEDI0457 with durvalumab
Study Purpose: This study was done to learn about the safety
of MEDI0457 with durvalumab and how
it works in participants with head and
neck cancers
Protocol Number: D8860C00005
Thank you
Thank you for taking part in the clinical study for the study drugs MEDI0457 and
durvalumab.
MedImmune sponsored this study and believes it is important to share the results.
An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1